Ruturaj Gaikwad is named the 'Player of the Match'. A superb 101 with the bat to rescue India A after a difficult start. Gaikwad continues to knock on the door of the senior side in ODI side with ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends on ...

WWE Clash in Italy marked the company’s first Italian PLE with a five-match showcase featuring four title tilts and the rematch between Brock Lesnar and Oba Femi. Overall, the trip was a success, and ...

Minecraft master Shark compares Java and Bedrock editions to test their differences in Minecraft. Watch what happens when 5 killer whales target one whale – they rip it apart There may be bizarre ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Editor's note: Follow the Rousey vs Carano card live Saturday with updates, results and analysis. Just one more sleep until Ronda Rousey takes on Gina Carano in the highly anticipated return to MMA ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

Elon Musk, famously a man with big ideas, is building a semiconductor plant vast enough to power those ambitions. Musk on Saturday announced what he calls the "Terafab," a semiconductor manufacturing ...

Taylor, who joined Recursion through the merger with Exscientia about 18 months ago, described how the combined company aims to address multiple points of failure in drug development. He said ...